Naukovi Novyny, Vol 2, Issue 7, July 30, 2020

In short

PDF

The COVID-19 pandemic continues. One of the problems in finding vaccines against COVID-19 is their possible reverse effect, the so-called antibody-mediated enhancement of viral infection [1]. There is also increasing evidence that SARS-CoV-2 can selectively kill insulin-producing cells, thus causing diabetes [2]. And antibodies from the blood plasma of those who got over COVID-19 may be the first available treatment for severe cases of this disease [3].

Used sources:

1. Coronavirus vaccine developers wary of errant antibodies, Ken Garber, Nature News, 5 June 2020 (doi: 10.1038/d41587-020-00016-w - https://www.nature.com/articles/d41587-020-00016-w)

2. Mounting clues suggest the coronavirus might trigger diabetes, Smriti Mallapaty, Nature 583, 16-17 (2020) (doi: 10.1038/d41586-020-01891-8 - https://www.nature.com/articles/d41586-020-01891-8)

3. Convalescent serum lines up as first-choice treatment for coronavirus, Cormac Sheridan, Nature Biotechnology 38, 655-658 (2020) (doi: 10.1038/d41587-020-00011-1 - https://www.nature.com/articles/d41587-020-00011-1)



previous article/